Table of Content

Table of Contents
Table of Contents
1 Industry Overview
1.1 Gastrointestinal Cancer Drugs Industry
Figure Gastrointestinal Cancer Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Gastrointestinal Cancer Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Gastrointestinal Cancer Drugs
1.2.2 Downstream
Table Application Segment of Gastrointestinal Cancer Drugs
Table Global Gastrointestinal Cancer Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Gastrointestinal Cancer Drugs Market by Type
3.1 By Type
3.1.1 Oncology
Table Major Company List of Oncology
3.1.2 Radiology
Table Major Company List of Radiology
3.1.3 Others
Table Major Company List of Others
3.2 Market Size
Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Type, in USD Million
Figure Global Gastrointestinal Cancer Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Type, in Volume
Figure Global Gastrointestinal Cancer Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Amgen Limited & Amgen Ireland Limited (Company Profile, Sales Data etc.)
4.1.1 Amgen Limited & Amgen Ireland Limited Profile
Table Amgen Limited & Amgen Ireland Limited Overview List
4.1.2 Amgen Limited & Amgen Ireland Limited Products & Services
4.1.3 Amgen Limited & Amgen Ireland Limited Business Operation Conditions
Table Business Operation of Amgen Limited & Amgen Ireland Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Bristol-Myers Squibb Company (Company Profile, Sales Data etc.)
4.2.1 Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Company Overview List
4.2.2 Bristol-Myers Squibb Company Products & Services
4.2.3 Bristol-Myers Squibb Company Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
4.3.1 F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Overview List
4.3.2 F. Hoffmann-La Roche Ltd. Products & Services
4.3.3 F. Hoffmann-La Roche Ltd. Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Eli Lilly and Company (Company Profile, Sales Data etc.)
4.4.1 Eli Lilly and Company Profile
Table Eli Lilly and Company Overview List
4.4.2 Eli Lilly and Company Products & Services
4.4.3 Eli Lilly and Company Business Operation Conditions
Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Johnson & Johnson Private Limited (Company Profile, Sales Data etc.)
4.5.1 Johnson & Johnson Private Limited Profile
Table Johnson & Johnson Private Limited Overview List
4.5.2 Johnson & Johnson Private Limited Products & Services
4.5.3 Johnson & Johnson Private Limited Business Operation Conditions
Table Business Operation of Johnson & Johnson Private Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 GlaxoSmithKline plc. (Company Profile, Sales Data etc.)
4.6.1 GlaxoSmithKline plc. Profile
Table GlaxoSmithKline plc. Overview List
4.6.2 GlaxoSmithKline plc. Products & Services
4.6.3 GlaxoSmithKline plc. Business Operation Conditions
Table Business Operation of GlaxoSmithKline plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Celgene Corporation (Company Profile, Sales Data etc.)
4.7.1 Celgene Corporation Profile
Table Celgene Corporation Overview List
4.7.2 Celgene Corporation Products & Services
4.7.3 Celgene Corporation Business Operation Conditions
Table Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Pfizer Inc. (Company Profile, Sales Data etc.)
4.8.1 Pfizer Inc. Profile
Table Pfizer Inc. Overview List
4.8.2 Pfizer Inc. Products & Services
4.8.3 Pfizer Inc. Business Operation Conditions
Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Sanofi (Company Profile, Sales Data etc.)
4.9.1 Sanofi Profile
Table Sanofi Overview List
4.9.2 Sanofi Products & Services
4.9.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Novartis AG (Company Profile, Sales Data etc.)
4.10.1 Novartis AG Profile
Table Novartis AG Overview List
4.10.2 Novartis AG Products & Services
4.10.3 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Gastrointestinal Cancer Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Gastrointestinal Cancer Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Gastrointestinal Cancer Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Gastrointestinal Cancer Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Gastrointestinal Cancer Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Gastrointestinal Cancer Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Gastrointestinal Cancer Drugs Market Concentration, in 2020
Figure Europe Gastrointestinal Cancer Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Gastrointestinal Cancer Drugs MMarket Concentration, in 2020
Figure South America Gastrointestinal Cancer Drugs Market Concentration, in 2020
Figure Middle East & Africa Gastrointestinal Cancer Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospitals
Figure Gastrointestinal Cancer Drugs Demand in Hospitals, 2016-2020, in USD Million
Figure Gastrointestinal Cancer Drugs Demand in Hospitals, 2016-2020, in Volume
6.1.2 Demand in Specialized Cancer Treatment Centers
Figure Gastrointestinal Cancer Drugs Demand in Specialized Cancer Treatment Centers, 2016-2020, in USD Million
Figure Gastrointestinal Cancer Drugs Demand in Specialized Cancer Treatment Centers, 2016-2020, in Volume
6.1.3 Demand in Clinics
Figure Gastrointestinal Cancer Drugs Demand in Clinics, 2016-2020, in USD Million
Figure Gastrointestinal Cancer Drugs Demand in Clinics, 2016-2020, in Volume
6.1.4 Demand in Ambulatory Surgical Centers
Figure Gastrointestinal Cancer Drugs Demand in Ambulatory Surgical Centers, 2016-2020, in USD Million
Figure Gastrointestinal Cancer Drugs Demand in Ambulatory Surgical Centers, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Gastrointestinal Cancer Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Gastrointestinal Cancer Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Gastrointestinal Cancer Drugs Market Share in 2026, by Application, in USD Million
Table Gastrointestinal Cancer Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Gastrointestinal Cancer Drugs Market Growth 2021-2026, by Application, in Volume
Table Gastrointestinal Cancer Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Gastrointestinal Cancer Drugs Production 2016-2020, by Region, in USD Million
Table Gastrointestinal Cancer Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Region, in USD Million
Table Global Gastrointestinal Cancer Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Region, in Volume
Table Global Gastrointestinal Cancer Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Figure

List of Table
List of Table
1. Table Upstream Segment of Gastrointestinal Cancer Drugs
2. Table Application Segment of Gastrointestinal Cancer Drugs
3. Table Global Gastrointestinal Cancer Drugs Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Radiology
5. Table Major Company List of Others
6. Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Type, in USD Million
7. Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Type, in Volume
8. Table Global Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Type, in USD Million
9. Table Global Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Type, in Volume
10. Table Amgen Limited & Amgen Ireland Limited Overview List
11. Table Business Operation of Amgen Limited & Amgen Ireland Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
12. Table Bristol-Myers Squibb Company Overview List
13. Table Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table F. Hoffmann-La Roche Ltd. Overview List
15. Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Eli Lilly and Company Overview List
17. Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Johnson & Johnson Private Limited Overview List
19. Table Business Operation of Johnson & Johnson Private Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table GlaxoSmithKline plc. Overview List
21. Table Business Operation of GlaxoSmithKline plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Celgene Corporation Overview List
23. Table Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Pfizer Inc. Overview List
25. Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Sanofi Overview List
27. Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Novartis AG Overview List
29. Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table Global Gastrointestinal Cancer Drugs Sales Revenue 2016-2020, by Company, in USD Million
31. Table Global Gastrointestinal Cancer Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
32. Table Global Gastrointestinal Cancer Drugs Sales Volume 2016-2020, by Company, in Volume
33. Table Global Gastrointestinal Cancer Drugs Sales Volume Share 2016-2020, by Company, in Volume
34. Table Regional Demand Comparison List
35. Table Major Application in Different Regions
36. Table Gastrointestinal Cancer Drugs Demand Forecast 2021-2026, by Application, in USD Million
37. Table Gastrointestinal Cancer Drugs Demand Forecast 2021-2026, by Application, in Volume
38. Table Gastrointestinal Cancer Drugs Market Growth 2021-2026, by Application, in Volume
39. Table Gastrointestinal Cancer Drugs Market Share in 2026, by Application, in Volume
40. Table Gastrointestinal Cancer Drugs Production 2016-2020, by Region, in USD Million
41. Table Gastrointestinal Cancer Drugs Production 2016-2020, by Region, in Volume
42. Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Region, in USD Million
43. Table Global Gastrointestinal Cancer Drugs Market Share 2016-2020, by Region, in USD Million
44. Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Region, in Volume
45. Table Global Gastrointestinal Cancer Drugs Market Share 2016-2020, by Region, in Volume
46. Table North America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million
47. Table North America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume
48. Table Europe Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million
49. Table Europe Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume
50. Table Asia-Pacific Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million
51. Table Asia-Pacific Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume
52. Table South America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million
53. Table South America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume
54. Table Middle East & Africa Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million
55. Table Middle East & Africa Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume
56. Table Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Region, in USD Million
57. Table Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Region, in Volume
58. Table Price Factors List